This is a preview of subscription content, log in via an institution to check access.
Reference
Doshi JA, et al. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents. Journal of Clinical Oncology : JCO2017745091, 20 Dec 2017. Available from: URL: http://doi.org/10.1200/JCO.2017.74.5091
Rights and permissions
About this article
Cite this article
OOP costs increase abandonment of antineoplastic prescriptions. PharmacoEcon Outcomes News 794, 21 (2018). https://doi.org/10.1007/s40274-018-4619-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4619-6